Acadia Healthcare (NASDAQ:ACHC - Get Free Report) was upgraded by StockNews.com from a "sell" rating to a "hold" rating in a note issued to investors on Thursday.
ACHC has been the topic of a number of other reports. KeyCorp lowered their price target on Acadia Healthcare from $65.00 to $55.00 and set an "overweight" rating on the stock in a report on Wednesday, May 14th. Barclays decreased their target price on shares of Acadia Healthcare from $35.00 to $28.00 and set an "equal weight" rating for the company in a research report on Wednesday, May 14th. Bank of America dropped their price target on shares of Acadia Healthcare from $50.00 to $44.50 and set a "buy" rating on the stock in a research report on Friday, February 28th. Royal Bank of Canada decreased their price objective on shares of Acadia Healthcare from $64.00 to $43.00 and set an "outperform" rating for the company in a report on Monday, March 3rd. Finally, Guggenheim started coverage on Acadia Healthcare in a report on Wednesday, April 9th. They set a "buy" rating and a $36.00 target price on the stock. Four research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. According to data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average price target of $47.94.
Read Our Latest Analysis on Acadia Healthcare
Acadia Healthcare Stock Performance
Shares of NASDAQ:ACHC traded down $0.57 during trading on Thursday, hitting $22.94. 154,760 shares of the company traded hands, compared to its average volume of 2,289,039. The stock has a market capitalization of $2.11 billion, a price-to-earnings ratio of 7.52, a PEG ratio of 1.46 and a beta of 1.01. Acadia Healthcare has a one year low of $20.36 and a one year high of $82.40. The company has a quick ratio of 1.07, a current ratio of 1.07 and a debt-to-equity ratio of 0.60. The business's fifty day moving average is $25.96 and its 200-day moving average is $35.22.
Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last posted its earnings results on Monday, May 12th. The company reported $0.40 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.35 by $0.05. Acadia Healthcare had a net margin of 8.99% and a return on equity of 11.12%. The firm had revenue of $770.51 million during the quarter, compared to analyst estimates of $769.90 million. During the same period in the previous year, the business posted $0.84 EPS. Acadia Healthcare's revenue was up .3% on a year-over-year basis. As a group, equities analysts predict that Acadia Healthcare will post 3.38 earnings per share for the current fiscal year.
Institutional Inflows and Outflows
Hedge funds have recently added to or reduced their stakes in the business. Treasurer of the State of North Carolina boosted its stake in shares of Acadia Healthcare by 0.6% during the 4th quarter. Treasurer of the State of North Carolina now owns 40,005 shares of the company's stock worth $1,586,000 after acquiring an additional 250 shares in the last quarter. Nisa Investment Advisors LLC lifted its holdings in shares of Acadia Healthcare by 40.7% during the fourth quarter. Nisa Investment Advisors LLC now owns 1,040 shares of the company's stock valued at $41,000 after purchasing an additional 301 shares during the last quarter. Coldstream Capital Management Inc. increased its stake in Acadia Healthcare by 4.9% in the 4th quarter. Coldstream Capital Management Inc. now owns 6,470 shares of the company's stock worth $257,000 after purchasing an additional 303 shares in the last quarter. Covestor Ltd increased its stake in Acadia Healthcare by 27.2% in the 4th quarter. Covestor Ltd now owns 1,450 shares of the company's stock worth $58,000 after purchasing an additional 310 shares in the last quarter. Finally, Pacer Advisors Inc. raised its holdings in Acadia Healthcare by 2.4% during the 4th quarter. Pacer Advisors Inc. now owns 13,847 shares of the company's stock worth $549,000 after buying an additional 325 shares during the period.
Acadia Healthcare Company Profile
(
Get Free Report)
Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Acadia Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Acadia Healthcare wasn't on the list.
While Acadia Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.